HQY
Income statement / Annual
Last year (2025), HealthEquity, Inc.'s total revenue was $1.20 B,
an increase of 20.03% from the previous year.
In 2025, HealthEquity, Inc.'s net income was $96.70 M.
See HealthEquity, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
01/31/2025 |
01/31/2024 |
01/31/2023 |
01/31/2022 |
01/31/2021 |
01/31/2020 |
01/31/2019 |
01/31/2018 |
01/31/2017 |
01/31/2016 |
| Operating Revenue |
$1.20 B |
$999.59 M |
$861.75 M |
$756.56 M |
$733.57 M |
$531.99 M |
$287.24 M |
$229.53 M |
$178.37 M |
$126.79 M |
| Cost of Revenue |
$422.52 M
|
$376.95 M
|
$371.66 M
|
$332.85 M
|
$318.24 M
|
$206.08 M
|
$106.05 M
|
$94.61 M
|
$72.02 M
|
$54.19 M
|
| Gross Profit |
$777.26 M
|
$622.64 M
|
$490.09 M
|
$423.71 M
|
$415.33 M
|
$325.91 M
|
$181.19 M
|
$134.92 M
|
$106.36 M
|
$72.60 M
|
| Gross Profit Ratio |
0.65
|
0.62
|
0.57
|
0.56
|
0.57
|
0.61
|
0.63
|
0.59
|
0.6
|
0.57
|
| Research and Development Expenses |
$239.51 M
|
$218.81 M
|
$193.38 M
|
$157.36 M
|
$124.81 M
|
$77.58 M
|
$35.06 M
|
$27.39 M
|
$22.38 M
|
$16.83 M
|
| General & Administrative Expenses |
$132.26 M
|
$103.66 M
|
$95.63 M
|
$84.38 M
|
$84.49 M
|
$60.56 M
|
$33.04 M
|
$25.11 M
|
$20.15 M
|
$14.11 M
|
| Selling & Marketing Expenses |
$90.74 M
|
$79.27 M
|
$68.85 M
|
$58.61 M
|
$49.96 M
|
$43.95 M
|
$29.50 M
|
$23.14 M
|
$18.32 M
|
$13.30 M
|
| Selling, General & Administrative Expenses |
$223.00 M
|
$182.93 M
|
$164.48 M
|
$142.98 M
|
$134.46 M
|
$104.51 M
|
$62.54 M
|
$48.25 M
|
$38.47 M
|
$27.42 M
|
| Other Expenses |
$152.41 M
|
$0.00
|
$94.59 M
|
$82.79 M
|
$76.06 M
|
$34.70 M
|
-$1.85 M
|
-$2.23 M
|
-$1.09 M
|
-$589.00 K
|
| Operating Expenses |
$614.93 M
|
$504.28 M
|
$452.44 M
|
$383.14 M
|
$335.33 M
|
$216.79 M
|
$103.52 M
|
$80.50 M
|
$65.14 M
|
$46.46 M
|
| Cost And Expenses |
$1.04 B
|
$871.45 M
|
$824.10 M
|
$715.99 M
|
$653.57 M
|
$422.88 M
|
$209.57 M
|
$175.11 M
|
$137.16 M
|
$100.64 M
|
| Interest Income |
$13.91 M
|
$12.14 M
|
$1.76 M
|
$1.50 M
|
$1.05 M
|
$5.91 M
|
$1.68 M
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$60.63 M
|
$55.46 M
|
$48.42 M
|
$36.57 M
|
$34.88 M
|
$24.77 M
|
$0.00
|
$274.00 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$162.45 M
|
$153.08 M
|
$161.20 M
|
$137.19 M
|
$115.90 M
|
$55.35 M
|
$18.19 M
|
$15.95 M
|
$13.19 M
|
$8.60 M
|
| EBITDA |
$337.54 M |
$282.42 M |
$171.53 M |
$102.97 M |
$154.93 M |
$123.28 M |
$94.00 M |
$68.14 M |
$54.40 M |
$34.74 M |
| EBITDA Ratio |
0.28
|
0.28
|
0.2
|
0.14
|
0.21
|
0.23
|
0.33
|
0.3
|
0.3
|
0.27
|
| Operating Income Ratio |
0.14
|
0.13
|
0.05
|
0.05
|
0.11
|
0.14
|
0.27
|
0.24
|
0.23
|
0.21
|
| Total Other Income/Expenses Net |
-$46.30 M
|
-$53.09 M
|
-$47.15 M
|
-$42.50 M
|
-$29.87 M
|
-$33.85 M
|
-$1.85 M
|
-$2.23 M
|
-$1.09 M
|
-$589.00 K
|
| Income Before Tax |
$116.03 M
|
$75.04 M
|
-$38.10 M
|
-$66.74 M
|
$4.14 M
|
$43.16 M
|
$75.82 M
|
$52.19 M
|
$40.12 M
|
$25.55 M
|
| Income Before Tax Ratio |
0.1
|
0.08
|
-0.04
|
-0.09
|
0.01
|
0.08
|
0.26
|
0.23
|
0.22
|
0.2
|
| Income Tax Expense |
$19.33 M
|
$19.33 M
|
-$11.95 M
|
-$22.45 M
|
-$4.69 M
|
$3.49 M
|
$1.92 M
|
$4.83 M
|
$13.74 M
|
$8.94 M
|
| Net Income |
$96.70 M
|
$55.71 M
|
-$26.14 M
|
-$44.29 M
|
$8.83 M
|
$39.66 M
|
$73.90 M
|
$47.36 M
|
$26.38 M
|
$16.61 M
|
| Net Income Ratio |
0.08
|
0.06
|
-0.03
|
-0.06
|
0.01
|
0.07
|
0.26
|
0.21
|
0.15
|
0.13
|
| EPS |
1.11 |
0.65 |
-0.31 |
-0.53 |
0.12 |
0.59 |
1.2 |
0.79 |
0.45 |
0.29 |
| EPS Diluted |
1.09 |
0.64 |
-0.31 |
-0.53 |
0.12 |
0.58 |
1.17 |
0.77 |
0.44 |
0.28 |
| Weighted Average Shares Out |
$86.87 M
|
$85.56 M
|
$84.44 M
|
$83.13 M
|
$74.24 M
|
$67.03 M
|
$61.84 M
|
$60.30 M
|
$58.62 M
|
$56.72 M
|
| Weighted Average Shares Out Diluted |
$88.83 M
|
$86.96 M
|
$84.44 M
|
$83.13 M
|
$75.68 M
|
$68.45 M
|
$63.37 M
|
$61.85 M
|
$59.89 M
|
$58.86 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
